FONTEYNE PAUL R. 4
4 · Amylyx Pharmaceuticals, Inc. · Filed Jan 10, 2022
Insider Transaction Report
Form 4
FONTEYNE PAUL R.
Director
Transactions
- Purchase
Common Stock
2022-01-06$19.00/sh+3,947$74,993→ 3,947 total - Award
Stock Option (Right to Buy)
2022-01-06+8,400→ 8,400 totalExercise: $19.00Exp: 2032-01-06→ Common Stock (8,400 underlying)
Footnotes (1)
- [F1]This option shall vest in full on the date of the Corporation's 2022 Annual Stockholders Meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.